BSEGeneral8 Sept 2026 · 8 Sept 2026, 08:35 pm
Annual Report of the Company for FY 2025-26.
Orchid Pharma Ltd · 524372
✦ AI SummaryResults
Orchid Pharma Ltd has announced its Annual Report for FY 2025-26, along with the Notice of 33rd Annual General Meeting scheduled for September 29, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Orchid Pharma Ltd - 524372 - Reg. 34 (1) Annual Report.
Attachments (1)
📄pdf
Download →
9173803d-c576-421f-8c50-d8a9d14f5590.pdf
View document text
OrchidPharm~W
-- A Dhanuka Group Company ------------------------------------
September 07, 2026
National Stock Exchange of India Limited, BSE Limited
Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Dalal
Bandra (E), Mumbai-400051 Street, Fort, Mumbai- 400001
Symbol: ORCHPHARMA Scrip Code: 524372
Ref.: Regulation 34(1) and 30 read with Para A Part A of Schedule III of Securities
and Exchange Board of India (Listing Obligations and Disclosure
Reguirements) Regulations, 2015, as amended ("SEBI Listing Regulations")
Sub: Annual Report and Notice of 33rd Annual General Meeting of Orchid Pharma
Limited ("the Company") for the F.Y. 2025-26
Dear Sir/Madam,
This is in continuation to our earlier intimation dated September 03, 2026 stating the
information regarding the 33rd Annual General Meeting of the Company for the Financial Year
ended on March 31, 2026.
With reference to the captioned subject and pursuant to Regulation 30 read with Para A Part
A of Schedule III of SEBI Listing Regulations, please find enclosed herewith the Annual Report
of the Company for the F.Y.2025-26, inter- alia including the Notice of 33rd Annual General
Meeting of the Company, scheduled to be held on Tuesday, September 29,2026 at 12.00
Noon (1ST) through Video Conferencing / Other Audio Visual Means ("VC" / "OAVM"),
forming part of the said Annual Report. The same had been sent via email to the members
of the Company as on the cut-off date i.e. September 04, 2026, whose email address is
registered with the Registrar and Transfer Agent of the Company / Depository Participants
and letters have been dispatched to the members who have not so registered the email-id,
providing the web-link, including the exact path, where complete details of the Annual Report
is available.
The said Annual Report and Notice of 33rd Annual General Meeting are also available on the
website of the Company at https:/Iorchid-pharma.b
cd n. net/pdf/An nua I % 20Report%202025-26. pdf
You are requested to take above information on record.
Thanking You,
For Orchid Pharma Limited
Kapil Dayya
Company Secretary & Compliance Officer
M. No.: Fl0698
Encl.: as above
+91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994
Registered Office: Corporate Office:
Orchid Pharma Limited 15th Floor, Tower 1, DLF Corporate Greens, Sector 74A,
Plot Nos. 121-128, 128A-133, 138-151,159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India
Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India.